IndiaInfoline » Markets » NATCOPHARM

Natco Pharma Ltd - Share Price

NATCOPHARM

Open

1,092.15

Prev. Close

1,094.45

Turnover (lac.)

6,150

Day's High

1,092.15

Day's Low

1,055.00

52 Week's High

1,189.00

52 Week's Low

666.15

Book Value

229

Face Value

2

Mkt Cap (Cr.)

19,280

P/E

64.33

EPS

16.97

Divi. Yield

0.48

Natco Pharma LtdFinancials

Switch to
Consolidated
Standalone

Loading ...

Natco Pharma LtdNews & Updates

Meeting Type

Meeting Date

Resolution Type Description Of Resolution IiAS Recommendation

Peer Comparison

Name LTP PE Mar Cap NP Qtr Div. Yld Sales Qtr BV
Sun Pharmaceuticals Industries Ltd703.4074.70166,513.85327.391.083,119.04104.36
Divis Laboratories Ltd4,921.1565.52128,060.72487.930.411,718.39349.25
Dr Reddys Laboratories Ltd5,411.2548.7890,215.55311.500.463,313.501,032.72
Cipla Ltd950.5530.9876,469.70413.410.533,173.39247.04
Gland Pharma Ltd4,019.2563.7965,961.75350.680.001,153.90359.44

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.

Natco Pharma LtdSummary & Reports

No Company Summary found

Registered Office

Natco House,Road No 2 Banjara Hills,Hyderabad, Telangana,500033

Tell. : +91-040-23547532
Website : http://www.natcopharma.co.in
Email : investors@natcopharma.co.in

Registrar Office

12-10-167, Bharath Nagar, Hyderbad - 500018 INDIA

Tell. : +91-040-23818475/76/2
Website : www.vccilindia.com
Email : info@vccilindia.com

Latest Release by natco-pharma-ltd-share-price

View

- <

Reco. Price

Jul 08,2021 02:39 PM

Target Price

Target Returns:

0.00%

Result Express

Natco Pharma Ltd's Q2FY19 consolidated net profit rises 115.17% yoy to Rs181.60cr : Misses Estimates

Jul 26, 2021 07:01 PM

The company’s consolidated revenue stood at Rs543.50cr, up 27.37% yoy and 0.91% qoq.

Shareholding Snapshot

Loading ...

Corporate Action

  • Purpose

    Board Meeting

    Exp. Date

    17 Jun 2021

    Annc. Date

    08 Jun 2021

    NATCO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is sched... More

  • Purpose

    Board Meeting

    Exp. Date

    26 Mar 2021

    Annc. Date

    26 Mar 2021

    To acquire 0.96% stake in NATCO Pharma (Canada) Inc., after this acquisition NATCO Pharma (Canada) I... More

  • Purpose

    Dividend

    Annc. Date

    11 Feb 2021

    Effective. Date

    22 Feb 2021

    Divi. Type

    Interim 3

    Divi.(%)

    50

    Divi. Amt.

    1

    Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on ... More

  • Purpose

    Board Meeting

    Exp. Date

    11 Feb 2021

    Annc. Date

    03 Feb 2021

    NATCO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is sched... More